A new experimental blood test shows 92% accuracy in detecting ovarian cancer, including 88% accuracy in early stages when treatment outcomes are better. By leveraging biomarkers and AI, CU Cancer Center member Kian Behbakht, MD, says the test could overcome current diagnostic limitations and transform ovarian cancer detection.